UCB Pharma and Tanner Pharma Group announced they have initiated a partnership in Southeast Asia to enable access to innovative treatments for patients with epilepsy.

“We are proud to work with UCB to provide a means for epilepsy patients in Southeast Asia to access innovative medicines. This partnership reflects the types of companies Tanner strives to associate with.”

“We are proud to work with UCB to provide a means for epilepsy patients in Southeast Asia to access innovative medicines. This partnership reflects the types of companies Tanner strives to associate with,” said Rob Keel, Executive Vice President of the Managed Access Program division at Tanner Pharma.

Healthcare professionals in the covered Southeast Asia countries of Cambodia, Indonesia, Laos, Malaysia, Mongolia, Myanmar, Nepal, Philippines, Singapore, Republic of Korea, Thailand and Vietnam can request details by contacting Tanner